All Posts

All Posts

Immutep drops a US$370M deal... at 6:54pm

Immutep drops a US$370M deal... at 6:54pm

Dec 9, 2025

•

7 min read

A Tale of Two IPOs: Lessons From Saluda and Epiminder’s Tough Debuts

A Tale of Two IPOs: Lessons From Saluda and Epiminder’s Tough Debuts

Dec 8, 2025

•

11 min read

Are AI-Predicted Clinical Trials the Future of Drug Development?

Are AI-Predicted Clinical Trials the Future of Drug Development?

Dec 5, 2025

•

5 min read

The Moment Invion (IVX) Became “Investible” for me

The Moment Invion (IVX) Became “Investible” for me

Dec 4, 2025

•

7 min read

The Hidden Signals Found in AGM Updates

The Hidden Signals Found in AGM Updates

Dec 3, 2025

•

7 min read

Inside the Visionflex Lazarus Story

Inside the Visionflex Lazarus Story

Dec 2, 2025

•

6 min read

What happens when a biotech stock goes up on "no news"...

What happens when a biotech stock goes up on "no news"...

Dec 1, 2025

•

5 min read

Biotech green shoots emerge in Australia and the US

Biotech green shoots emerge in Australia and the US

Nov 28, 2025

•

4 min read

What does a "leveraged" clinical trial bet look like

What does a "leveraged" clinical trial bet look like

Nov 27, 2025

•

5 min read

Paul Hopper voted out, PIQ gets Reimbursement, Ethics Approval for RAC

Paul Hopper voted out, PIQ gets Reimbursement, Ethics Approval for RAC

Nov 26, 2025

•

6 min read

Philips swings big at ASX listed minnows

Philips swings big at ASX listed minnows

Nov 25, 2025

•

4 min read

Welcome to The Armchair Analyst

Welcome to The Armchair Analyst

Nov 23, 2025

•

2 min read